ERO1A and hepatocellular carcinoma: ERO1L is highly expressed in various types of human malignances, including but not limited to hepatocellular carcinoma (HCC), pancreatic cancer, gastric cancer, and breast cancer, which are associated with tumor progression and metastasis [7–10].